Stragen Pharma’s Erythromycin withdrawn from market
…product had not met the requirements of good manufacturing practice, according to Medicalonline.hu. Erythromycin does not have a standard marketing authorisation in Hungary, but, at the request of certain healthcare providers, it became available through individual import licences.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)